Strauss Borrelli PLLC, a leading data breach law firm, is investigating Ferring Pharmaceuticals, Inc. (“Ferring”) regarding its recent data breach. The Ferring data breach may have involved sensitive personal information belonging to an undetermined number of individuals.
ABOUT FERRING PHARMACEUTICALS, INC.:
Ferring is a privately owned, research-driven, specialty biopharmaceutical group based in Switzerland. Founded in 1950, Ferring specializes in reproductive medicine and maternal health, and in areas of gastroenterology and urology.2 Additionally, Ferring focuses on innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy.2 Headquartered in Saint-Prex, Switzerland, Ferring has operating subsidiaries in more than 50 countries and markets its medicines in over 100 countries.2 In 1980, Ferring launched its United States operation which today is headquartered in Parsippany, New Jersey.
WHAT HAPPENED?
Recently, Ferring reported to the Attorney General of the Commonwealth of Massachusetts that it had experienced a data breach in which sensitive personal identifiable information in its systems may have been accessed and acquired. According to the breach notice, on October 16, 2024, Ferring discovered unusual activity associated with an employee’s email account.1 As a result, Ferring launched an investigation to determine the nature of the incident.
Through its investigation, Ferring discovered that sensitive personal information in its systems may have been viewed and obtained by an unauthorized third party during the incident. As a result, Ferring began a review of the data to determine what information had been impacted as well as identify the specific individuals affected. On October 28, 2024, Ferring completed this review. While the information impacted varies depending on the individual, the type of information potentially exposed includes:
- Name
- Social Security number
- Work profile details (e.g., job history, current project, education profile)
As a result of the data breach, Ferring began mailing data breach notification letters to impacted individuals. Based on the breach notice sent to Massachusetts residents, Ferring is providing affected individuals with a list of the specific types of sensitive information impacted and complimentary credit monitoring services. A link to the form breach notification letters that Ferring filed with the Attorney General of the Commonwealth of Massachusetts is below.
If you received a breach notification letter from Ferring Pharmaceuticals, Inc.:
We would like to speak with you about your rights and potential legal remedies in response to this data breach. Please fill out the form, below, or contact us at 872.263.1100 or sam@straussborrelli.com.
